163 related articles for article (PubMed ID: 2113031)
61. Synthesis of vitamin K1 2,3-epoxide in rat liver mitochondria.
Inyangetor PT; Thierry-Palmer M
Arch Biochem Biophys; 1988 May; 262(2):389-96. PubMed ID: 2835004
[TBL] [Abstract][Full Text] [Related]
62. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
[TBL] [Abstract][Full Text] [Related]
63. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
[TBL] [Abstract][Full Text] [Related]
64. DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Effect of substituents on autoxidation rates.
Buffinton GD; Ollinger K; Brunmark A; Cadenas E
Biochem J; 1989 Jan; 257(2):561-71. PubMed ID: 2494985
[TBL] [Abstract][Full Text] [Related]
65. Requirement for iron for the production of hydroxyl radicals by rat liver quinone reductase.
Dicker E; Cederbaum AI
J Pharmacol Exp Ther; 1993 Sep; 266(3):1282-90. PubMed ID: 7690400
[TBL] [Abstract][Full Text] [Related]
66. DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation.
Lind C; Hochstein P; Ernster L
Arch Biochem Biophys; 1982 Jun; 216(1):178-85. PubMed ID: 6285828
[No Abstract] [Full Text] [Related]
67. A note on the inhibition of DT-diaphorase by dicoumarol.
Preusch PC; Siegel D; Gibson NW; Ross D
Free Radic Biol Med; 1991; 11(1):77-80. PubMed ID: 1718826
[TBL] [Abstract][Full Text] [Related]
68. Superoxide dismutase and catalase prevent the formation of reactive oxygen species during reduction of cyclized dopa ortho-quinone by DT-diaphorase.
Baez S; Linderson Y; Segura-Aguilar J
Chem Biol Interact; 1994 Nov; 93(2):103-16. PubMed ID: 8082230
[TBL] [Abstract][Full Text] [Related]
69. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
[TBL] [Abstract][Full Text] [Related]
70. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
Thijssen HH; Janssen YP; Vervoort LT
Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
[TBL] [Abstract][Full Text] [Related]
71. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene.
Smart RC; Zannoni VG
Mol Pharmacol; 1984 Jul; 26(1):105-11. PubMed ID: 6749127
[TBL] [Abstract][Full Text] [Related]
72. Quinone reductases of higher plants.
Spitsberg VL; Coscia CJ
Eur J Biochem; 1982 Sep; 127(1):67-70. PubMed ID: 7140760
[TBL] [Abstract][Full Text] [Related]
73. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
Ross PJ; Shearer MJ; Diplock AT; Schey SA
Br J Haematol; 1991 Feb; 77(2):195-200. PubMed ID: 2004021
[TBL] [Abstract][Full Text] [Related]
74. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
Hildebrandt EF; Suttie JW
Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
[TBL] [Abstract][Full Text] [Related]
75. The two-electron quinone reductase DT-diaphorase generates and maintains the antioxidant (reduced) form of coenzyme Q in membranes.
Beyer RE; Segura-Aguilar J; di Bernardo S; Cavazzoni M; Fato R; Fiorentini D; Galli MC; Setti M; Landi L; Lenaz G
Mol Aspects Med; 1997; 18 Suppl():S15-23. PubMed ID: 9266502
[TBL] [Abstract][Full Text] [Related]
76. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
[TBL] [Abstract][Full Text] [Related]
77. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
[TBL] [Abstract][Full Text] [Related]
78. Temporal variation in the effects of warfarin on the vitamin K cycle.
Soulban G; Labrecque G; Bélanger PM
Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
[TBL] [Abstract][Full Text] [Related]
79. Sex-dependent activities of quinone reductases in rabbits indicate higher risk of bladder cancer in the male.
Mohandas J; Chennell AF; Duggin GG; Horvath JS; Tiller DJ
Carcinogenesis; 1986 Mar; 7(3):353-6. PubMed ID: 2419007
[TBL] [Abstract][Full Text] [Related]
80. Protection against reactive oxygen species by NAD(P)H: quinone reductase induced by the dietary antioxidant butylated hydroxyanisole (BHA). Decreased hepatic low-level chemiluminescence during quinone redox cycling.
Wefers H; Komai T; Talalay P; Sies H
FEBS Lett; 1984 Apr; 169(1):63-6. PubMed ID: 6201394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
